Company Filing History:
1 out of 108 
1 out of 56 
Years Active: 2025
Title: Emma Wroblewski: Innovator in Vaccine Development
Introduction
Emma Wroblewski is a prominent inventor based in Leeds, GB. She has made significant contributions to the field of immunology, particularly in the development of innovative vaccine technologies. Her work focuses on the assembly of Virus Like Particles (VLPs), which are crucial for advancing vaccine efficacy.
Latest Patents
Emma holds 1 patent related to her groundbreaking work. The patent, titled "Virus Like Particle," discloses the assembly of VLPs using both native and artificial packaging signals. This technology is pivotal for creating vaccines and immunological compositions aimed at combating human and animal viral pathogens.
Career Highlights
Throughout her career, Emma has been associated with esteemed institutions such as the University of Leeds and the University of York. Her research has garnered attention for its potential to revolutionize vaccine development and improve public health outcomes.
Collaborations
Emma has collaborated with notable colleagues, including German Leonov and Simon White. These partnerships have enriched her research and contributed to the advancement of her innovative projects.
Conclusion
Emma Wroblewski's contributions to vaccine technology through her patent on Virus Like Particles exemplify her dedication to improving health solutions. Her work continues to inspire future innovations in the field of immunology.